Reviews in Medical Virology

1.2k papers and 50.3k indexed citations i.

About

The 1.2k papers published in Reviews in Medical Virology in the last decades have received a total of 50.3k indexed citations. Papers published in Reviews in Medical Virology usually cover Infectious Diseases (581 papers), Epidemiology (530 papers) and Immunology (179 papers) specifically the topics of Herpesvirus Infections and Treatments (177 papers), Cytomegalovirus and herpesvirus research (166 papers) and SARS-CoV-2 and COVID-19 Research (153 papers). The most active scholars publishing in Reviews in Medical Virology are Erik De Clercq, William D. Rawlinson, Nguyen Tien Huy, Michelle O’Neill and Máirín Ryan.

In The Last Decade

Fields of papers published in Reviews in Medical Virology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Reviews in Medical Virology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Reviews in Medical Virology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Reviews in Medical Virology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Reviews in Medical Virology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025